A Limited Sampling Model for Estimation of Total and Unbound Mycophenolic Acid (MPA) Area Under the Curve (AUC) in Hematopoietic Cell Transplantation (HCT)

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Therapeutic Drug Monitoring

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.ftd.0000211821.73231.8aPMID 16778725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate Mofetil in Islet Cell Transplant: Variable Pharmacokinetics but Good Correlation Between Total and Unbound Concentrations

  2005cited by this paper
• Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation

  2005cited by this paper
• Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.

  2005cited by this paper
• Cyclosporin A, but Not Tacrolimus, Inhibits the Biliary Excretion of Mycophenolic Acid Glucuronide Possibly Mediated by Multidrug Resistance-Associated Protein 2 in Rats

  2004cited by this paper
• Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy

  2004cited by this paper
• A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.

  2004cited by this paper
• Comparison of Liquid Chromatography-Tandem Mass Spectrometry with a Commercial Enzyme-Multiplied Immunoassay for the Determination of Plasma MPA in Renal Transplant Recipients and Consequences for Therapeutic Drug Monitoring

  2004cited by this paper
• Long‐Term Changes in Mycophenolic Acid Exposure in Combination with Tacrolimus and Corticosteroids Are Dose Dependent and Not Reflected by Trough Plasma Concentration: A Prospective Study in 100 De Novo Renal Allograft Recipients

  2003cited by this paper
• Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.

  2002cited by this paper
• Mycophenolic Acid and Mycophenolic Acid Glucuronide Pharmacokinetics in Pediatric Liver Transplant Recipients: Effect of Cyclosporine and Tacrolimus Comedication

  2002cited by this paper
• Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy

  2001cited by this paper
• Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion

  2001cited by this paper
• Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid

  2001cited by this paper
• Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

  2001cited by this paper
• Determination of mycophenolate area under the curve by limited sampling strategy.

  2001cited by this paper
• Limited sampling strategy for mycophenolic acid area under the curve.

  2000cited by this paper
• Mycophenolic acid concentrations are associated with cardiac allograft rejection.

  2000cited by this paper
• Evaluation of Limited Sampling Strategies for Estimation of 12-Hour Mycophenolic Acid Area Under the Plasma Concentration–Time Curve in Adult Renal Transplant Patients

  2000influential reference
• Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite.

  2000cited by this paper
• Clinical Pharmacokinetics of Mycophenolate Mofetil

  1998cited by this paper
• The pharmacokinetic‐pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

  1998cited by this paper
• Some suggestions for measuring predictive performance

  1981cited by this paper

• A limited sampling model to estimate the area under the curve of mycophenolic acid in hematopoietic stem cell transplantation recipients

  2024cites this paper
• Limited sampling strategy to predict free mycophenolic acid area under the concentration–time curve in paediatric patients with nephrotic syndrome

  2023cites this paper
• A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration–Time Curve Estimation

  2021cites this paper
• The Evaluation of Multiple Linear Regression–Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome

  2021cites this paper
• Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients

  2020cites this paper
• A Limited Sampling Strategy for Therapeutic Drug Monitoring of Mycophenolate Mofetil for Prophylaxis of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplantation

  2020cites this paper
• Screening and identification of a Penicillium brevicompactum strain isolated from the fruiting body of Inonotus obliquus and the fermentation production of mycophenolic acid

  2019cites this paper
• Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients

  2018cites this paper
• Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients

  2017cites this paper
• Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II

  2016cites this paper
• A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.

  2016cites this paper
• Découverte de nouveaux marqueurs pharmacogénomiques de la maladie du greffon contre l'hôte en transplantation de cellules souches hématopoïétiques

  2014cites this paper
• [Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC].

  2014cites this paper
• Limited Sampling Strategy of Mycophenolic Acid in Adult Kidney Transplant Recipients: Influence of the Post‐Transplant Period and the Pharmacokinetic Profile

  2013cites this paper
• A Limited Sampling Schedule to Estimate Mycophenolic Acid Area Under the Concentration‐Time Curve in Hematopoietic Cell Transplantation Recipients

  2012cites this paper
• A Possible Simplification for the Estimation of Area Under the Curve (AUC0–12) of Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus

  2011cites this paper
• Niveau de preuve du suivi thérapeutique pharmacologique de l’acide mycophénolique administré pour la prévention des réactions du greffon contre l’hôte au cours des greffes de cellules souches avec un conditionnement réduit

  2011cites this paper
• Evaluation of limited sampling designs to estimate maximal concentration and area under the curve of mizoribine in pediatric patients with renal disease.

  2011cites this paper
• [Level of evidence for therapeutic drug monitoring of MPA in hematopoietic stem cell transplantation].

  2011cites this paper
• [Not Available].

  2011cites this paper
• Pharmacokinetic modelling and development of Bayesian estimators for the therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic cell transplantation

  2010cites this paper
• A Reliable Limited Sampling Strategy for the Estimation of Mycophenolic Acid Area Under the Concentration Time Curve in Adult Renal Transplant Patients in the Stable Posttransplant Period

  2010cites this paper
• Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis.

  2010cites this paper
• Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

  2010cites this paper
• Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

  2009cites this paper
• Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation

  2009cites this paper
• Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease.

  2009cites this paper
• Two sampling time profiles for the abbreviated estimation of mycophenolic acid area under the curve in adult renal transplant recipients treated with mycophenolate mofetil and concomitant tacrolimus

  2009cites this paper
• Inflammation and its echo in atherosclerosis

  2009cites this paper
• A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine

  2009cites this paper
• Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies

  2008cites this paper
• Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT)

  2008cites this paper
• Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation

  2008influential citation
• Pharmacocinétique du mofétilmycophénolate en greffe hématopoïétique : étude d’un cas pédiatrique

  2008cites this paper
• Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients

  2007cites this paper